Servier

Welcome to our page. Servier is committed to therapeutic progress to serve patient needs.

Servier is an independent international pharmaceutical group governed by a foundation. With its unique governance model, the Group is committed to therapeutic progress to serve patients and integrates the patient voice at every stage of the medicine life cycle. As a leading global player in cardiology and venous diseases, Servier aims to become a leading innovator in oncology and neurology. Throug

h precision medicine, the Group intends to offer targeted therapeutic solutions for a limited number of rare diseases and invests nearly 20% of its brand-name sales in R&D. Headquartered in France, Servier relies on its more than 20,000 employees and a solid geographic presence with medicines distributed in more than 130 countries. In the 2024/25 financial year, the Group achieved revenues of €6.9 billion.

----

To report a suspected adverse event with a Servier drug 👉 https://bit.ly/435zpoI

22/04/2026

🧬 Why molecular testing matters in AML
Molecular testing plays a key role in understanding Acute Myeloid Leukemia ( ).

Alongside karyotype analysis, it helps identify genetic mutations that can influence prognosis — and, crucially, reveal molecular targets for specific treatments.

During a bone marrow examination, advanced techniques such as immunophenotyping allow researchers and clinicians to analyze proteins on leukemic cells. This helps distinguish AML from other types of leukemia and supports more informed treatment decisions.

🎥 Watch the whole video on our YouTube channel
https://www.youtube.com/watch?v=irCTwc6WS94

21/04/2026

💬 “I want to take you through some moment of my old and new life to show you how recovery looks like and to remind anyone currently fighting: there is a life after waiting for you.”

🤔 Do you remember Max? We met him two years ago, shortly after he was diagnosed with Acute Myeloid Leukemia (AML). At 30, Max had just returned from traveling the world when his life suddenly changed.

On this World AML Day, we stand with patients, caregivers and healthcare professionals. Because behind every diagnosis, there is a story. And behind every story, there is hope.

Learn more about AML 👉 https://servier.com/en/newsroom/folders/understanding-acute-myeloid-leukemia/

You can also find Maximilian on Instagram.

20/04/2026

🗓️ Tomorrow is !

⚠️ Why AML symptoms shouldn’t be overlooked
One of the challenges of Acute Myeloid Leukemia ( ) is that its symptoms are often unspecific and easy to dismiss.

Some signs are linked to a shortage of blood cells:
🩸 Anemia can cause fatigue, shortness of breath, paleness, or pain.
🦠 A lack of white blood cells may lead to frequent infections and fever.
🩹 Low platelet levels can result in easy bruising, unusual bleeding, or petechiae.

There are also more general symptoms, such as fever, weight loss, swollen gums, and a persistent feeling of being unwell.

When symptoms are unclear, a simple blood test can reveal abnormalities and help guide further investigations.

🎥 Watch the whole video on our YouTube channel
https://www.youtube.com/watch?v=irCTwc6WS94

19/04/2026

🗓️ is coming!

🎗️ Acute Myeloid Leukemia ( ) is an aggressive blood cancer representing ~25% of adult leukemias, with ~ 161,000 new cases diagnosed worldwide each year.

AML is characterized by the rapid proliferation of abnormal myeloid cells in the bone marrow. Without prompt treatment, the disease progresses quickly.

Despite therapeutic advances over the past decade substantial unmet needs persist.

🧬 At Servier, we are committed to fighting rare cancers and contributing to progress in oncology.

Join us in supporting AML patients, caregivers, and researchers in their daily fight against this rare cancer.

Learn more about Acute Myeloid Leukemia at 👉 https://bit.ly/4aGoTsK

18/04/2026

🩸 This April 21, we will raise awareness for Acute Myeloid Leukemia (AML). What is Acute Myeloid Leukemia (AML)?

Acute Myeloid Leukemia, or AML, is a type of blood cancer that starts in the bone marrow — where blood cells are normally produced and mature into red blood cells, platelets, and white blood cells.

In AML, genetic changes block this maturation process, leading to the rapid accumulation of abnormal, immature cells called blasts. These cells multiply quickly and crowd out healthy blood cells, which is why AML is described as acute.

🎥 Watch the whole video on our YouTube channel
https://www.youtube.com/watch?v=irCTwc6WS94

17/04/2026

Chronic diseases often reshape a patient’s identity and daily life.
For Steven, adapting to heart failure and diabetes meant redefining his “normal”.

Globally chronic illnesses are impacting not only physical health but also social roles and family dynamics. 🧑‍🧑‍🧒

When patients are supported with education, peer groups and caregiver involvement, their quality of life significantly improves. Steven’s message illustrates a deeper truth: resilience grows when patients are not alone, but surrounded by informed support and a community of care.

by Servier embodies this spirit by creating resources and awareness for patients and caregivers. 💙

16/04/2026

The World Health Organization reports that treatment adherence is a challenge for many patients with chronic diseases. This lack of adherence remains one of the biggest challenges in modern healthcare.

💬 Ravi explains how small strategies make a real difference in his daily life, such as:
🔔 Reminders on his phone
💊 Pill boxes
📋 Structured routines

Studies confirm that these simple habits improve adherence and reduce long-term risks such as cardiovascular disease or kidney complications. His experience shows that with the right support, patients can turn treatment into a sustainable routine.

by Servier contributes by providing practical solutions and shared knowledge to strengthen adherence. 💙

15/04/2026

📢 “Don't turn your back on your health!” Michael's advice is simple but effective. Staying attentive to your health not only reduces risks. It helps you feel stronger and more in control of your life. When patients follow their care plan, they maintain a better quality of life.

Michael shows that attitude is the most important thing. Regular care and consistency help you feel stronger and more in control of your life. 💪

His journey is encouraging: even with chronic diseases, it is possible to develop resilience, protect your future, and continue to enjoy life.

by Servier brings together science, care, and practical tools to support patients on this journey.

14/04/2026

🌍 At Servier, solidarity is more than a commitment — it’s a collective movement.
Through Mécénat Servier, our Group and our employees actively contribute to a more inclusive and resilient society 🤝

From health and humanitarian action to education, culture and social cohesion, we support initiatives that address urgent needs while building long-term impact.
💙 In times of humanitarian crises, we strengthen healthcare resilience.
💙 Through a holistic approach to care, we help restore confidence and dignity.
💙 By promoting equal opportunities, we act for a fairer future.
💙 And by fostering employee engagement, we turn skills and energy into meaningful action.

Together with our partners and volunteers, we are driven by one shared ambition: serving the common good.

Read the Mécénat Servier 2024-2025 Annual Report 👉 https://mecenat.servier.com/2024-2025-annual-report/

13/04/2026

At a glance, in 2024-2025, Mécénat Servier was:
📌 5 areas of commitment,
📌 24 countries involved,
📌 20 nonprofit organizations supported,
📌 1,946 employee commitments,
📌 15 Sustainable Development Goals (SGDs) contributed to out of the 17 set by the UN for 2030.

Established in 2016, Mécénat Servier brings together the Group’s philanthropic and solidarity initiatives around one clear ambition: making a real, lasting impact.
Since its creation, we’ve supported 62 nonprofit organizations in 35 countries, responding to humanitarian emergencies, restoring access to healthcare, promoting equal opportunity, and strengthening civic engagement.

Read the Mécénat Servier 2024-2025 Annual Report 👉 https://mecenat.servier.com/2024-2025-annual-report/

12/04/2026

🌍 Growing in solidarity — together, we make a difference.
Since 2016, we have supported 62 nonprofit organizations across 35 countries. Our mission? To turn solidarity into concrete action.

The Mécénat Servier 2024–2025 Annual Report shows how, thanks to our employees and partners, we support vulnerable communities through both emergency response and long-term solutions.

In 2024–2025: 💙 1,946 employee commitments | 20 nonprofit organizations | 24 countries supported.

Behind these numbers are people — colleagues who choose to act, to help, and to build hope where it’s most needed.
Together, we’re building a fairer, more resilient world — one project, one community, one gesture at a time 🌱

Happy reading 👉 https://mecenat.servier.com/2024-2025-annual-report/

11/04/2026

🗣️ “It’s important to me to help people understand what Parkinson’s really is, and especially to break stereotypes— like the idea that it only affects older people and is only about tremors.”

To mark the , we had the pleasure of speaking 🗣️ with Valérie.

Valérie was only 44 when she was diagnosed with Parkinson’s disease — after years of symptoms, uncertainty, and misdiagnosis. Like many, she never imagined this condition could affect someone so young.

Through her journey, Valérie chose transparency, resilience, and sharing. As a mother, a patient, and now a voice for awareness, she reminds us how powerful understanding, support, and community can be.

🎥 Watch their inspiring story

You can also find Valérie - on Instagram.

Adresse

50, Rue Carnot
Suresnes
92150

Téléphone

+33 1 55 72 60 00

Site Web

https://servier.com/

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque Servier publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.

Raccourcis

Vous voulez que votre pratique soit Clinique la plus cotée à Suresnes ?

Type

Centre de recherche médicale

Our Story

Servier is an international pharmaceutical company governed by a non-profit foundation, with headquarters in Suresnes, France.

With a strong international presence in 149 countries and a turnover of € 4.2 billion in 2018, Servier employs 22.000 people worldwide.

Entirely independent, Servier reinvests 25% of its revenue (excluding generic drugs) in research and development and uses all its profits for development.